Home » Topics » BioWorld Science

BioWorld Science
RSS

FXV-673, a new factor Xa inhibitor, compares favorably to heparin in canine thrombosis model

Sep. 12, 2001

Orally active DP receptor antagonist prevents allergic inflammation in guinea pigs

Sep. 12, 2001

A new anxioselective compound --SL-65.1498-- characterized

Sep. 12, 2001

FDA grants fast track designation for Repligen's secretin

Sep. 12, 2001

Clinical trial of Cur-61414 commences for treatment of sporadic BCC

Sep. 12, 2001

Topiglan development continues to move forward

Sep. 12, 2001

Results presented on CryoLife's cancer treatment drug delivery system

Sep. 12, 2001

Vertex and Array BioPharma establish small-molecule drug discovery agreement

Sep. 12, 2001

Joint Onco TCS clinical development program expanded

Sep. 12, 2001

FDA accepts Estrasorb NDA for review

Sep. 12, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Jiangsu Nhwa Pharmaceutical patents new κ-opioid receptor antagonists
BioWorld Science
Jiangsu Nhwa Pharmaceutical Co. Ltd. has disclosed κ-opioid receptor antagonists that are potentially useful for the treatment of neurological disorders.